Medicare Enrolled

Pamela Ingram, CRNP

Physician Assistant · Du Bois, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
100 HOSPITAL AVE, Du Bois, PA 15801
8143753800
Registered in NPPES since 2009
NPI: 1508193855 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Ingram from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Ingram? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Ingram

Pamela Ingram is a physician assistant in Du Bois, PA, with 16 years of NPI registration. Based on federal Medicare data, Ingram performed 322 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Ingram received a total of $4,594 from 56 pharmaceutical and/or device companies across 266 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Ingram is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ Top 34% volume in PA $4,594 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
322
Medicare services
Top 34% in PA for physician assistant
Not available
Unique patients (not deduplicated)
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
122 $63 $100
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
107 $95 $165
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
69 $43 $80
New patient office visit, complex (60-74 min) 24 $121 $235
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,594
Total received (2021-2024)
Avg $1,149/year across 4 years
Top 6% in PA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
266
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,329
2023
$1,409
2022
$1,120
2021
$735

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$197
Incyte Corporation
$184
Janssen Biotech, Inc.
$147
ABBVIE INC.
$102
E.R. Squibb & Sons, L.L.C.
$75
Eisai Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$68
PFIZER INC.
$57
Ipsen Biopharmaceuticals, Inc
$45
GENZYME CORPORATION
$39
Merck Sharp & Dohme LLC
$37
TAIHO ONCOLOGY, INC.
$37
Aveo Pharmaceuticals, Inc.
$34
EMD Serono, Inc.
$33
Gilead Sciences, Inc.
$33
BeiGene USA, Inc.
$32
Sumitomo Pharma America, Inc.
$31
Rigel Pharmaceuticals, Inc.
$30
Genentech USA, Inc.
$20
ARRAY BIOPHARMA INC
$15
Exelixis Inc.
$14
AstraZeneca Pharmaceuticals LP
$14
Celgene Corporation
$13
Top 3 companies account for 39.7% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$463
Incyte Corporation
$345
Janssen Biotech, Inc.
$316
GlaxoSmithKline, LLC.
$232
PFIZER INC.
$215
Amgen Inc.
$192
ABBVIE INC.
$178
Takeda Pharmaceuticals U.S.A., Inc.
$176
Merck Sharp & Dohme LLC
$168
Eisai Inc.
$127
AstraZeneca Pharmaceuticals LP
$125
E.R. Squibb & Sons, L.L.C.
$116
GENZYME CORPORATION
$108
Sumitomo Pharma America, Inc.
$93
Celgene Corporation
$89
BeiGene USA, Inc.
$87
Seagen Inc.
$85
Rigel Pharmaceuticals, Inc.
$83
Daiichi Sankyo Inc.
$76
Genentech USA, Inc.
$74
Regeneron Healthcare Solutions, Inc.
$70
EMD Serono, Inc.
$65
Ipsen Biopharmaceuticals, Inc
$63
ADC Therapeutics America, Inc.
$62
EISAI INC.
$60
Pharmacosmos Therapeutics Inc.
$60
Blueprint Medicines Corporation
$60
JAZZ PHARMACEUTICALS INC.
$59
TAIHO ONCOLOGY, INC.
$53
Alexion Pharmaceuticals, Inc.
$52
Gilead Sciences, Inc.
$46
ARRAY BIOPHARMA INC
$46
AVEO Pharmaceuticals, Inc.
$45
NOVARTIS PHARMACEUTICALS CORPORATION
$37
Aveo Pharmaceuticals, Inc.
$34
PharmaEssentia USA Corporation
$34
Myovant Sciences Inc.
$33
Karyopharm Therapeutics Inc.
$31
TerSera Therapeutics LLC
$29
Stemline Therapeutics Inc.
$29
Mirati Therapeutics, Inc.
$28
Astellas Pharma US Inc
$26
AbbVie Inc.
$24
Myriad Genetic Laboratories, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
G1 Therapeutics, Inc.
$18
Coherus Biosciences Inc.
$17
MorphoSys, US Inc.
$16
Foundation Medicine, Inc.
$15
Exelixis Inc.
$14
Acrotech Biopharma LLC
$13
Tactile Systems Technology Inc
$13
Lilly USA, LLC
$13
SOBI, INC
$13
Acceleron Pharma, Inc.
$13
PUMA BIOTECHNOLOGY, INC.
$13
Top 3 companies account for 24.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ENJAYMO · EPKINLY · ERLEADA · EVUSHELD · EXKIVITY · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Flexitouch Plus · GAVRETO · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Pomalyst · REBLOZYL · RYBREVANT · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · TABRECTA · TECENTRIQ · TECVAYLI · TEVIMBRA · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · XALKORI · XPOVIO · XTANDI · Xermelo · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a physician assistant in Du Bois?
Compare physician assistants in the Du Bois area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants in nearby ZIP areas
52
County median income
$60,181
Nearest hospital to ZIP centroid (approximate)
PENN HIGHLANDS DUBOIS
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Ingram is a clinical cardiology specialist, with moderate Medicare volume, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Ingram experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Ingram performed 122 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Ingram receive payments from pharmaceutical companies?
Yes. Ingram received a total of $4,594 from 56 companies across 266 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Ingram's costs compare to other physician assistants in Du Bois?
Ingram's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Ingram) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →